Literature DB >> 11888932

Real-time optical imaging of primary tumor growth and multiple metastatic events in a pancreatic cancer orthotopic model.

Michael Bouvet1, Jinwei Wang, Stephanie R Nardin, Rounak Nassirpour, Meng Yang, Eugene Baranov, Ping Jiang, A R Moossa, Robert M Hoffman.   

Abstract

We report here whole-body optical imaging, in real time, of genetically fluorescent pancreatic tumors growing and metastasizing to multiple sites in live mice. The whole-body optical imaging system is external and noninvasive. Human pancreatic tumor cell lines, BxPC-3 and MiaPaCa-2, were engineered to stably express high-levels of the Aequorea victoria green fluorescent protein (GFP). The GFP-expressing pancreatic tumor cell lines were surgically orthotopically implanted as tissue fragments in the body of the pancreas of nude mice. Whole-body optical images visualized real-time primary tumor growth and formation of metastatic lesions that developed in the spleen, bowel, portal lymph nodes, omentum, and liver. Intravital images in the opened animal confirmed the identity of whole-body images. The whole-body images were used for real-time, quantitative measurement of tumor growth in each of these organs. Intravital imaging was used for quantification of growth of micrometastasis on the liver and stomach. Whole-body imaging was carried out with either a trans-illuminated epi-fluorescence microscope or a fluorescence light box, both with a thermoelectrically cooled color CCD camera. The simple, noninvasive, and highly selective imaging made possible by the strong GFP fluorescence allowed detailed simultaneous quantitative imaging of tumor growth and multiple metastasis formation of pancreatic cancer. The GFP imaging affords unprecedented continuous visual monitoring of malignant growth and spread within intact animals without the need for anesthesia, substrate injection, contrast agents, or restraint of animals required by other imaging methods. The GFP imaging technology presented in this report will facilitate studies of modulators of pancreatic cancer growth, including inhibition by potential chemotherapeutic agents.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11888932

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  65 in total

1.  Establishment of green fluorescent protein-expressing hepatocellular carcinoma cell lines with different metastatic potential: relevant models for in vivo monitoring of metastasis and angiogenesis.

Authors:  Yang Xu; Hui-Chuan Sun; Bo Tian; Yan Li; Jie Chen; Jun Chen; Dong-Mei Gao; Qiong Xue; Zhao-You Tang
Journal:  J Cancer Res Clin Oncol       Date:  2004-07       Impact factor: 4.553

2.  Coupled mathematical model of tumorigenesis and angiogenesis in vascular tumours.

Authors:  M D Cooper; M L Tanaka; I K Puri
Journal:  Cell Prolif       Date:  2010-12       Impact factor: 6.831

Review 3.  Molecular imaging in drug discovery and development: potential and limitations of nonnuclear methods.

Authors:  Markus Rudin; Martin Rausch; Markus Stoeckli
Journal:  Mol Imaging Biol       Date:  2005 Jan-Feb       Impact factor: 3.488

4.  Knockdown of the β(1) integrin subunit reduces primary tumor growth and inhibits pancreatic cancer metastasis.

Authors:  John J Grzesiak; Hop S Tran Cao; Douglas W Burton; Sharmeela Kaushal; Fabian Vargas; Paul Clopton; Cynthia S Snyder; Leonard J Deftos; Robert M Hoffman; Michael Bouvet
Journal:  Int J Cancer       Date:  2011-04-13       Impact factor: 7.396

5.  LY293111 improves efficacy of gemcitabine therapy on pancreatic cancer in a fluorescent orthotopic model in athymic mice.

Authors:  Rene Hennig; Jacinthe Ventura; Ralf Segersvard; Erin Ward; Xian-Zhong Ding; Sambasiva M Rao; Borko D Jovanovic; Takeshi Iwamura; Mark S Talamonti; Richard H Bell; Thomas E Adrian
Journal:  Neoplasia       Date:  2005-04       Impact factor: 5.715

6.  Gene transfer and expression of enhanced green fluorescent protein in variant HT-29c cells.

Authors:  Min Wang; Lars Boenicke; Bradley D Howard; Ilka Vogel; Holger Kalthoff
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

7.  Redirecting apoptosis to aponecrosis induces selective cytotoxicity to pancreatic cancer cells through increased ROS, decline in ATP levels, and VDAC.

Authors:  Richard D Dinnen; Yuehua Mao; Wanglong Qiu; Nicholas Cassai; Vesna N Slavkovich; Gwen Nichols; Gloria H Su; Paul Brandt-Rauf; Robert L Fine
Journal:  Mol Cancer Ther       Date:  2013-10-14       Impact factor: 6.261

8.  Advantages of fluorescence-guided laparoscopic surgery of pancreatic cancer labeled with fluorescent anti-carcinoembryonic antigen antibodies in an orthotopic mouse model.

Authors:  Cristina A Metildi; Sharmeela Kaushal; George A Luiken; Robert M Hoffman; Michael Bouvet
Journal:  J Am Coll Surg       Date:  2014-03-02       Impact factor: 6.113

9.  A fluorescent orthotopic model of metastatic cervical carcinoma.

Authors:  Rob A Cairns; Richard P Hill
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

10.  Dual-color fluorescence imaging in a nude mouse orthotopic glioma model.

Authors:  Xuepeng Zhang; Xuguang Zheng; Feng Jiang; Zheng Gang Zhang; Mark Katakowski; Michael Chopp
Journal:  J Neurosci Methods       Date:  2009-05-15       Impact factor: 2.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.